Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02378012 · ClinicalTrials.gov registry record · NA
iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02378012 is a NA study that was terminated before completion, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 6 participants.
The verdict
NCT02378012, a NA study, was terminated before completion, sponsored by Ohio State University Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This randomized clinical trial studies iPad use in reducing anxiety and depression in patients undergoing bone marrow transplant. A tablet device like the iPad can provide access to music, television, movies, books, and the Internet. It also contains a video conferencing system that can allow patients to communicate with family members and other members of their social support team. With these capabilities, an iPad distribution program may help lessen patient anxiety and depression during a hospital stay. Monitoring iPad use by patients may help doctors better understand how patients use their computers and tablets while in the hospital so that the software and applications of the iPad can be made more useful.
Interventions
- OTHER Questionnaire Administration
- OTHER Computer-Assisted Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-03-19 |
| Est. Completion | 2014-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02378012
The ClinicalTrials.gov registry entry for NCT02378012 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT02378012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02378012 about?
NCT02378012 is a clinical study titled "iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant". This randomized clinical trial studies iPad use in reducing anxiety and depression in patients undergoing bone marrow transplant. A tablet device like the iPad can provide access to music, television, movies, books, and the Internet. It also contains a video conferencing system that can allow patien...
What is the current status of trial NCT02378012?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2014-03-19. Estimated completion is 2014-09-06.
What interventions are being tested in trial NCT02378012?
The interventions under investigation include: Questionnaire Administration (OTHER), Computer-Assisted Intervention (OTHER).
Who is sponsoring clinical trial NCT02378012?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.